When was PacGenomics founded?

PacGenomics was founded in 2011 and raised its 1st funding round 4 years after it was founded.

Where is PacGenomics located?

PacGenomics is headquartered in Agoura Hills, United States.

How many employees does PacGenomics have?

As of Dec 31, 2022, PacGenomics has 7 employees, reflecting a 40% year-over-year growth in headcount.

Is PacGenomics a funded company?

PacGenomics is a funded company, having raised a total of $4.5M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Jan 08, 2015.

When was the latest funding round of PacGenomics?

PacGenomics' latest funding was a $***** Series A round on Jan 12, 2015, with participation from 0 investor. Its primary sector is Oncology. In United States, the Oncology sector has seen $1.88B in funding in 2026 to date.

Where does PacGenomics rank among its competitors?

PacGenomics ranks 174th amongst 1092 active competitors, of which 207 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Delfi Diagnostics, which secured $34.3M in Dec, 2025.

Who are the top competitors of PacGenomics?

PacGenomics' top competitors include Guardant Health, Natera and 10X Genomics. Among them, Delfi Diagnostics secured the most recent funding round in December, 2025.

PacGenomics - 2026 Company Profile, Funding & Competitors

Company Details

PacGenomics is a clinical genetics laboratory providing genetic testing tools and services using its single-cell technologies. It has developed a cancer screening tool that uses NanoVelcro microchip to isolate rare circulating tumor cells from blood, then utilizes a series of immunocytochemistry staining reactions, with automated detection of the target cells for excision with Laser Capture Microdissection. It is also developing a non-invasive prenatal screening (NIPS) tool which enables complete information on all chromosomes using maternal blood. Additionally, it provides Preimplantation Genetic Screening (PGS), NGS, and embryo biopsy services.

Key Metrics

Founded Year

2011

Location

Agoura Hills, United States

Stage

Series A

Total Funding

$4.5M in 2 rounds

Latest Funding Round

Series A, Jan 12, 2015, $*****

Ranked

174^th among 1092 active competitors

Employee Count

7 as on Dec 31, 2022

Similar Companies

Guardant Health & 1375 more

View PacGenomics' full profile

PacGenomics is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Pacgenomics CIN: 1627824 , United States, Active		$1M - $5M (As on Jan 12, 2015)	-	-
Pacgenomics Inc CIN: 452989041 , United States, Active	Dec 31, 2010	-	23 (As on Dec 31, 2024)	-

PacGenomics has raised a total funding of $4.5M over 2 rounds. Its first funding round was on Jan 08, 2015.

Here is the list of recent funding rounds of PacGenomics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 12, 2015	5866976	Series A	7507749	2196167	2309215	3459021
Jan 08, 2015	6681791	Series A	9030180	4490502	9245760	8449461

Access funding benchmarks and valuations. Sign up today!

View details of PacGenomics's funding rounds and investors

PacGenomics' employee count trend

PacGenomics has 7 employees as of Dec 22. The total employee count is 40.0% more than what it was in Dec 21. Here is PacGenomics's employee count trend over the years:

Uncover PacGenomics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PacGenomics include Guardant Health, Natera and 10X Genomics. Here is the list of Top 10 competitors of PacGenomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Guardant Health 2012, Redwood City (United States), Public	Developer of digital sequencing technology for cancer detection	$557M	Orbimed, Sequoia Capital & 25 others	79/100
2nd	Natera 2004, Redwood City (United States), Public	Developer of cell-free DNA testing for oncology, women’s health, and organ health	$152M	Harmony Partners, Harmony Venture Partners ... & 17 others	77/100
3rd	10X Genomics 2012, Pleasanton (United States), Public	Developer of single-cell, spatial, and in situ tools for high-resolution biological analysis	$243M	Fidelity Investments, Meritech & 13 others	77/100
4th	Myriad Genetics 1991, United States, Public	Developer of molecular diagnostics and personalized medicine for cancer	-	Grayhawk Capital, TriplePoint Capital & 6 others	72/100
5th	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Coatue & 19 others	71/100
6th	Foundation Medicine 2010, Cambridge (United States), Acquired	Provider of genomics-based diagnostics test for cancer	$96.5M	Deerfield, Casdin Capital & 11 others	71/100
7th	Exact Sciences 1995, Madison (United States), Acquired	Provider of non-invasive molecular diagnostic testing solutions for cancer	-	Petrillo Capital, Back Bay Group & 8 others	71/100
8th	Prenetics 2009, Hong Kong (China), Public	Online platform for genetic and diagnostic health testing that helps identify health risks	$67.6M	Beyond Ventures, Ping An Ventures & 21 others	70/100
9th	BillionToOne 2015, San Francisco (United States), Public	Provider of cell-free cancer liquid biopsy test	$389M	Hummingbird Ventures, Adams Street Partners ... & 29 others	69/100
10th	Delfi Diagnostics 2019, Baltimore (United States), Series B	Provider of DNA sequencing for cancer detection	$332M	Orbimed, Merck Global Health Innovation Fund ... & 19 others	68/100
174th	PacGenomics 2011, Agoura Hills (United States), Series A	Genetic testing tools and services using single-cell technologies	$4.5M	-	40/100